Biopharmaceutical

Arrowhead Pharmaceuticals

$80.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$3.42 (-4.10%) Today
$0.00 (0.00%) As of 10:04 PM UTC after-hours

Why Robinhood?

You can buy or sell ARWR and other stocks, options, and ETFs commission-free!

About ARWR

Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA. The listed name for ARWR is Arrowhead Pharmaceuticals, Inc. Common Stock.

CEO
Christopher Richard Anzalone
Employees
232
Headquarters
Pasadena, California
Founded
1989
Market Cap
8.08B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
934.12K
High Today
$83.58
Low Today
$79.49
Open Price
$83.50
Volume
558.84K
52 Week High
$86.75
52 Week Low
$19.51

Collections

ARWR Earnings

-$0.48
-$0.22
$0.03
$0.29
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available Feb 4, After Hours

You May Also Like

LWAY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure